These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1093 related articles for article (PubMed ID: 19412954)

  • 41. Multicenter study on deep brain stimulation in Parkinson's disease: an independent assessment of reported adverse events at 4 years.
    Hariz MI; Rehncrona S; Quinn NP; Speelman JD; Wensing C;
    Mov Disord; 2008 Feb; 23(3):416-21. PubMed ID: 18067188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective comparative study on cost-effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease.
    Valldeoriola F; Morsi O; Tolosa E; Rumià J; Martí MJ; Martínez-Martín P
    Mov Disord; 2007 Nov; 22(15):2183-91. PubMed ID: 17724747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chronic stimulation of the subthalamic nucleus increases daily on-time without dyskinesia in advanced Parkinson's disease.
    Portman AT; van Laar T; Staal MJ; Rutgers AW; Journee HL; Leenders KL
    Parkinsonism Relat Disord; 2006 Apr; 12(3):143-8. PubMed ID: 16460986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bilateral subthalamic nucleus stimulation improves health-related quality of life in Parkinsonian patients.
    Erola T; Karinen P; Heikkinen E; Tuominen J; Haapaniemi T; Koivukangas J; Myllylä V
    Parkinsonism Relat Disord; 2005 Mar; 11(2):89-94. PubMed ID: 15734666
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Freezing of gait after bilateral subthalamic nucleus stimulation for Parkinson's disease.
    Davis JT; Lyons KE; Pahwa R
    Clin Neurol Neurosurg; 2006 Jul; 108(5):461-4. PubMed ID: 16139421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deep brain stimulation parameters associated with neuropsychological changes in subthalamic nucleus stimulation for refractory Parkinson's disease.
    Schoenberg MR; Mash KM; Bharucha KJ; Francel PC; Scott JG
    Stereotact Funct Neurosurg; 2008; 86(6):337-44. PubMed ID: 18854660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson's disease.
    Dafsari HS; Dos Santos Ghilardi MG; Visser-Vandewalle V; Rizos A; Ashkan K; Silverdale M; Evans J; Martinez RCR; Cury RG; Jost ST; Barbe MT; Fink GR; Antonini A; Ray-Chaudhuri K; Martinez-Martin P; Fonoff ET; Timmermann L;
    Brain Stimul; 2020; 13(6):1697-1705. PubMed ID: 33038595
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson's disease.
    Daniels C; Krack P; Volkmann J; Pinsker MO; Krause M; Tronnier V; Kloss M; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G; Witt K
    Mov Disord; 2010 Aug; 25(11):1583-9. PubMed ID: 20589868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mood stability during acute stimulator challenge in Parkinson's disease patients under long-term treatment with subthalamic deep brain stimulation.
    Berney A; Panisset M; Sadikot AF; Ptito A; Dagher A; Fraraccio M; Savard G; Pell M; Benkelfat C
    Mov Disord; 2007 Jun; 22(8):1093-6. PubMed ID: 17394245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Subthalamic nucleus stimulation in Parkinson's disease: postoperative CT-MRI fusion images confirm accuracy of electrode placement using intraoperative multi-unit recording.
    Shin M; Lefaucheur JP; Penholate MF; Brugières P; Gurruchaga JM; Nguyen JP
    Neurophysiol Clin; 2007 Dec; 37(6):457-66. PubMed ID: 18083502
    [TBL] [Abstract][Full Text] [Related]  

  • 51. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease.
    Moreau C; Defebvre L; Destée A; Bleuse S; Clement F; Blatt JL; Krystkowiak P; Devos D
    Neurology; 2008 Jul; 71(2):80-4. PubMed ID: 18420482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuro-psychiatric therapy during chronic subthalamic stimulation in Parkinson's disease.
    Zibetti M; Pesare M; Cinquepalmi A; Rosso M; Castelli L; Rizzi L; Bergamasco B; Lanotte M; Lopiano L
    Parkinsonism Relat Disord; 2009 Feb; 15(2):128-33. PubMed ID: 18515169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deep brain stimulation of the subthalamic nucleus and cognitive functions in Parkinson's disease.
    Klempírová O; Jech R; Urgosík D; Klempír J; Spacková N; Roth J; Růzicka E
    Prague Med Rep; 2007; 108(4):315-23. PubMed ID: 18780643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improvement of sleep quality in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
    Hjort N; Østergaard K; Dupont E
    Mov Disord; 2004 Feb; 19(2):196-9. PubMed ID: 14978676
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reoperation for suboptimal outcomes after deep brain stimulation surgery.
    Ellis TM; Foote KD; Fernandez HH; Sudhyadhom A; Rodriguez RL; Zeilman P; Jacobson CE; Okun MS
    Neurosurgery; 2008 Oct; 63(4):754-60; discussion 760-1. PubMed ID: 18981887
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deep-brain stimulation in the subthalamic nuclei improves balance performance in patients with Parkinson's disease, when tested without anti-parkinsonian medication.
    Nilsson MH; Törnqvist AL; Rehncrona S
    Acta Neurol Scand; 2005 May; 111(5):301-8. PubMed ID: 15819709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deep brain stimulation of the subthalamic nucleus improves intrinsic alertness in Parkinson's disease.
    Fimm B; Heber IA; Coenen VA; Fromm C; Noth J; Kronenbuerger M
    Mov Disord; 2009 Aug; 24(11):1613-20. PubMed ID: 19533754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Early deep brain stimulation for Parkinson's disease].
    Schnitzler A; Fuchs G; Baas H; Dillmann U; Hilker R; Oechsner M
    Fortschr Neurol Psychiatr; 2010 Mar; 78 Suppl 1():S37-40. PubMed ID: 20195941
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
    Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
    Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Zibetti M; Merola A; Rizzi L; Ricchi V; Angrisano S; Azzaro C; Artusi CA; Arduino N; Marchisio A; Lanotte M; Rizzone M; Lopiano L
    Mov Disord; 2011 Nov; 26(13):2327-34. PubMed ID: 22012750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.